NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
As a condition with a variety of symptoms and causes, depression affects different people in different ways. This also means that health care providers can offer a variety of treatments, to differing degrees of success. Most people have heard about traditional talk therapies, antidepressant medications, or recommended changes in diet, exercise, and other lifestyle habits. But there's another treatment that isn't as well-known: transcranial magnetic stimulation, or TMS. You might be surprised to learn just how much research has gone into TMS over the years. So, what is TMS therapy exactly, and how long has TMS been around?
Physicians have long been intrigued by the effects of electricity on the brain. As far back as 46 A.D., Scribonius Largus, the court physician to the Roman emperor Claudius, compiled a book of medical treatments known as Compositiones. It included a recommendation for applying live electric torpedo fish onto patients' scalps to cure headaches. A thousand years later, the physician Ibn-Sidah prescribed using live electric catfish to treat epilepsy.
In the mid-20th century, scientists began applying electrodes to the brain in electroconvulsive therapy (ECT). While ECT is still
used successfully, it requires patients to go under general anesthesia and is reserved for those with severe mental illnesses who have not responded to other therapies. It is understood that nerve cells operate by
generating electric signals that trigger muscles, for example, or activate chemicals in the brain. To investigate how these processes work and better develop treatments, researchers sought safer ways to introduce electricity to the body.
In 1985, Anthony Barker and his colleagues were the first to use a magnetic stimulator to activate the brain. This development took advantage of a basic discovery made by physicist Michael Faraday made back in 1831. Barker's device, placed on a patient's head, generated a magnetic pulse that passed painlessly through the scalp and induced an electric current in the underlying brain tissue. Within a few years, scientists engineered improvements to allow TMS devices to deliver repeated magnetic pulses.
Although the new TMS device was originally meant to be a research tool, Hans Martin Kolbinger and his colleagues published a pilot study in 1995 showing evidence that TMS helped patients with major depressive disorder (MDD). The next year, leading TMS researchers convened to set detailed guidelines on how TMS should be used safely and ethically in laboratory research and clinical settings. With these guidelines in place, scientists expanded tests using TMS, initially involving patients with depression who did not find relief from existing treatments.
In 2007, results were published of a major clinical trial that conducted TMS treatments on 301 patients with MDD who had not benefited from other therapies. It found that TMS was safe and could alleviate symptoms of MDD. By then, more than a decade of studies had shown that TMS therapy produced few and minor side effects. In 2008, the U.S. Food and Drug Administration cleared TMS therapy as an accepted depression treatment.
Since 2008, numerous studies have demonstrated that TMS therapy can provide relief for those whose depression symptoms haven't improved after medications and/or talk therapy. Further, TMS has often provided more relief when used in conjunction with other therapies.
Antidepressant medications, for example, have been shown to help relieve symptoms in 40% to 60% of patients. Some people don't like to take antidepressants, even if they are effective, because they sometimes come with side effects such as insomnia, weight gain, headaches, blurred vision, rashes, high blood pressure, and gastrointestinal and sexual problems. TMS is a non-drug, non-invasive therapy with a long history of producing few side effects. Patients sit in a comfortable chair with a TMS device near their scalp. The magnetic pulses are not painful, but rather feel like a gentle tapping, as they stimulate areas of the brain that are known to regulate moods.
When it comes to just how exactly TMS works, scientists have many theories. TMS may increase electrical activity and/or blood flow to brain regions that may be slowed down because these were lacking. Magnetic fields from TMS may help growing brain cells align into more efficient circuits to convey brain signals. Or, TMS could help trigger the release of chemicals that speed brain signaling.
Because these mechanisms logically could also aid in other brain conditions, researchers have explored using TMS to treat other conditions. In 2018, the
FDA approved TMS as a treatment for
obsessive-compulsive disorder. What's more, TMS is also being tested and used to help patients with Parkinson's disease, migraines,
strokes,
head traumas, and
multiple sclerosis. Talk with your doctor to see if
TMS therapy might be a beneficial option for you.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.